Main > HEMATOLOGY > ImmunoDeficiency > Treatment > Co.: CH. S. ImmuneGlobulin Normal+
Co.: CH. S. ImmuneGlobulin Normal+'s subsections
+Recombinant Human Hyaluronidase
Company
EU Adult Approval Date: 2013.05.
EU Pediatric Approval Date: 2016.06
EU Pediatric Launch Date: 2016.07
TradeMark
TradeMark Web-Site
Co.: CH. S. ImmuneGlobulin Normal+'s products
This section has no products